Innovation in medical technologies is something of a paradox. On one hand, new technologies that drive innovation can manifest at breakneck speed. On the other hand, the pace at which those technologies breed innovations that reach full commercialization and patient impact can be glacial by comparison. What have been the most significant changes with…
Revolutionizing Pediatrics: Innovations in Medical Device Design & Development. A Pediatric Tech Talk Webinar with GCMI, June 21, 2023 – 12:00 p.m. Eastern “Innovation in pediatric technologies that address unmet clinical needs lags behind innovation for adult populations in large part due to its relatively small market size and ROI (return on investment) prospects…
Evaluating your new artificial organ technology’s readiness for preclinical work or just want to get together to talk about the latest in preclinical testing, bioskills training or medtech innovation across the board? Connect with GCMI and T3 Labs at ASAIO 2023. At GCMI, medtech and medical device innovation are at the core of our efforts…
The National Center for Biotechnology Information describes mechanical circulatory assist devices as, “commonly used in the treatment of severe heart failure as bridges to cardiac transplant, as destination therapy for patients who are not transplant candidates, and as bridges to recovery and “decision-making.” These devices, which can be used to support the left or right…
A “Catheter Gripping Tool” solving an unmet need as GCMI’s grows its roster of collaborative medtech innovations with the Children’s Mercy Kansas City Center for Pediatric Innovation. Human beings are generally good at improvisation. Assembly calls for a 10mm socket? Try this handy crescent wrench right here and maybe it will do. What happened…
Quick Insights Aligned in Acceleration: Indeed, the Most Expensive Preclinical Study is the One You Have to Do Twice As mentioned in a post last month, our colleagues at Within3 are using technology to accelerate pharma and medtech innovation in some very interesting ways, all of which center around actionable insights generation and insights management. …
Roughly one decade ago, scientists made significant improvements in viral vectors’ ability to deliver genetic therapeutics. Those therapies use genetic material like DNA to manipulate a patients’ own cells. Cellular (cell) therapies transfer cells into the patient whether they are the patients’ own cells or cells derived from another location or donor cells. Because…
Life science companies of all shapes and sizes rely on preclinical contract research organizations (CROs) to generate the data and reports required to bring their innovations to market. To do this effectively, and in a capital efficient manner, each entity needs to understand what they need from the other, when they need it, why…
The phrase “personalized medicine” has been thrown about by so many for so long in healthcare as to defy definition: or require post graduate work in any one of dozens of specific clinical or technological fields. For the sake of brevity, 3D printing and bioresorbable material technologies are actively realizing personalized medicine in the…
Medical technology innovation and critical supporting service providers are not only working through pent up demand for delayed projects from 2020 and 2021, but also striving to advance technologies that reduce cost and improve patient outcomes developed much more recently. The U.S. FDA is striving to support innovation with new programs and guidelines that improve…